Jazz Pharmaceuticals PLC (JAZZ)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 4,093,760 | 3,737,000 | 3,085,730 | 3,965,190 | 3,659,740 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $4,093,760K)
= 0.00
The debt-to-capital ratio for Jazz Pharmaceuticals PLC has consistently been at 0.00 for the years 2020 to 2024. This indicates that the company has not utilized debt as a significant portion of its capital structure during this period. A debt-to-capital ratio of 0.00 suggests that the company's capital primarily consists of equity rather than debt, which can be a positive indicator of financial stability and lower financial risk. It shows that the company is not highly leveraged and may have a strong financial position with less financial obligation to creditors. Investors and creditors may view this low debt-to-capital ratio favorably, as it signifies a lower level of financial risk and potential for sustainable growth.
Peer comparison
Dec 31, 2024